# Merit Medical Systems, Inc. (MMSI) Stock Analysis: A Strong Buy with 12% Upside Potential

- Link: https://www.directorstalkinterviews.com/merit-medical-systems-inc-mmsi-stock-analysis-a-strong-buy-with-12-upside-potential/4121259895
- Published: 2026-08-10T10:24:49+01:00
- Author: Madison Wilson

Merit Medical Systems, Inc. (MMSI), a prominent player in the healthcare sector,
is capturing investor attention with its robust growth trajectory and promising 
analyst ratings. Specializing in the design and manufacture of medical instruments
and supplies, Merit Medical is well-positioned within the industry, boasting a market
capitalization of $5.32 billion. This Utah-based company is gaining traction, further
bolstered by its expansive international footprint, spanning markets from the United
States to South Africa.

The current stock price of Merit Medical stands at $89.04, having experienced a 
slight increase of 1.35 USD, or 0.02%, recently. The 52-week range of $60.31 to 
$93.18 highlights the stock’s resilience and growth potential, with analysts projecting
a target price range between $83.00 and $114.00. The average target price of $99.82
suggests a potential upside of 12.10%, making it an attractive option for growth-
minded investors.

Despite the absence of a trailing P/E ratio and other valuation metrics such as 
PEG, price/book, and price/sales, the stock’s forward P/E of 19.31 indicates reasonable
expectations for future earnings. The company has demonstrated a commendable revenue
growth rate of 9.50%, alongside an EPS of 2.43. Merit Medical’s return on equity
stands at 9.19%, reflecting efficient use of shareholder capital to generate profits.

From a cash flow perspective, Merit Medical exhibits strength with a free cash flow
of approximately $173.9 million. This financial health, coupled with a payout ratio
of 0.00%, indicates that the company is reinvesting earnings to fuel further growth
rather than distributing dividends.

Analyst sentiment towards Merit Medical is overwhelmingly positive, with 9 buy ratings
and 2 hold ratings, and no sell ratings. This consensus underscores the company’s
robust market position and growth prospects. The technical indicators also paint
a favorable picture, with the stock trading above both its 50-day and 200-day moving
averages, at $71.98 and $76.15 respectively. An RSI of 73.42 points to a strong 
momentum, albeit bordering on overbought territory, which investors should monitor.

Merit Medical’s diverse product portfolio spans cardiovascular and endoscopy segments,
offering a wide range of single-use medical products critical for interventional,
diagnostic, and therapeutic procedures. This diversity not only mitigates risks 
associated with reliance on a single product line but also positions the company
to capitalize on various opportunities across global healthcare markets.

Operating in a highly competitive and innovative industry, Merit Medical continues
to leverage its expertise and expansive distribution network, reaching customers
worldwide through a mix of direct sales and partnerships. As the demand for advanced
medical solutions grows, particularly in emerging markets, Merit Medical is strategically
placed to harness these opportunities.

Investors considering Merit Medical Systems as a potential addition to their portfolio
should weigh the company’s growth metrics, strong analyst support, and the broader
healthcare industry’s resilience. With a solid market presence and a clear path 
for expansion, Merit Medical Systems presents a compelling case for long-term growth.

Share on:
